No medical treatment has been reliably shown to halt or reverse disease progression in hypertrophic cardiomyopathy , but the results of several pilot studies have suggested beneficial effects of angiotensin II receptor blockers on left ventricular hypertrophy and fibrosis , which are predictive of an adverse outcome .